GPAS 2025: Shaping the Future of Bleeding Disorder Care
The World Federation of Hemophilia (WFH) recently shared an insightful post on X:
”At GPAS 2025, global experts explored the evolving treatment landscape for bleeding disorders—highlighting innovations in hemophilia and VWD care, and addressing challenges in access and reimbursement. A timely look at what’s ahead in care.”
At GPAS 2025, leading global experts Jamie O’Hara, Alok Srivastava, Nathan Connell and Cedric Hermans convened to discuss the rapidly evolving treatment landscape for bleeding disorders.
Sessions spotlighted innovation in hemophilia and von Willebrand disease (VWD) care, including novel therapeutics, personalized medicine, and gene-based approaches.
Critical dialogue also addressed ongoing challenges in access, affordability, and reimbursement.
The meeting offered a timely and forward-looking perspective on the future of equitable care delivery!
Find more footage from the webinar in the gallery.
Hemostasis Today, your daily update on the World of Hemophilia.
-
Feb 26, 2026, 15:24Nancy Shapiro: Excited to See This Publication on Current Landscape of Anticoagulation Stewardship Released
-
Feb 26, 2026, 15:15Ahmed Nasreldein: Stay Current on Key Updates in Ischemic and Hemorrhagic Stroke
-
Feb 26, 2026, 15:15Shannon Farmer: What Happens to Vital Signs Pre and Post 1-Unit and 2-Unit RBC Transfusion?
-
Feb 26, 2026, 15:08Emmanuel J Favaloro: When Is A ‘Subtype’ of VWD Not Really VWD?
-
Feb 26, 2026, 15:03Gregory Piazza: Importance of Recognizing PE As A Wide Spectrum of Presentations and Greater Range of Adverse Outcomes
-
Feb 26, 2026, 14:57Abdulla A. Damluji: Sex As An Effect Measure Modifier Between Frailty and Outcomes in AMI Patients
-
Feb 26, 2026, 14:48Ney Carter Borges: The APERITIF Trial Clarifies Rivaroxaban’s Role in LVT
-
Feb 26, 2026, 14:44Wolfgang Miesbach: Synovitis and Haemophilia in Focus at GTH2026
-
Feb 26, 2026, 14:40Al-Ola Abdallah: How Much Does It Cost to Publish in Hematology and Oncology Journals